Biology Reference
In-Depth Information
Wu KL, Beverloo B, Velthuizen SJ, Sonneveld P (2007a) Sequential analysis of chromosome
aberrations in multiple myeloma during disease progression. Clin Lymphoma Myeloma
7:280-285
Wu KL, Beverloo B, Lokhorst HM, Segeren CM, van der Holt B, Steijaert MM, Westveer PH,
Poddighe PJ, Verhoef GE, Sonneveld P (2007b) Abnormalities of chromosome 1p/q are
highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for
the outcome of high-dose chemotherapy in patients with multiple myeloma. Br J Haematol
136:615-623
Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX (1999)
Centrosome
amplification
and
a defective
G2-M
cell
cycle
checkpoint
induce
genetic
instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 3:389-395
Yabuta N, Okada N, Ito A, Hosomi T, Nishihara S, Sasayama Y, Fujimori A, Okuzaki D, Zhao H,
Ikawa M, Okabe M, Nojima H (2007) Lats2 is an essential mitotic regulator required for the
coordination of cell division. J Biol Chem 282:19259-19271
Yuregir OO, Sahin FI, Yilmaz Z, Kizilkilic E, Karakus S, Ozdogu H (2009) Fluorescent in situ
hybridization studies in multiple myeloma. Hematology 14:90-94
Zeng X, Shaikh FY, Harrison MK, Adon AM, Trimboli AJ, Carroll KA, Sharma N, Timmers C,
Chodosh LA, Leone G, Saavedra HI (2010) The Ras oncogene signals centrosome
amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. Oncogene
29:5103-5112
Zhan F, Hardin J, Kordsmeier B, Bumm K, Zheng M, Tian E, Sanderson R, Yang Y, Wilson C,
Zangari M, Anaissie E, Morris C, Muwalla F, van Rhee F, Fassas A, Crowley J, Tricot G,
Barlogie B, Shaughnessy J Jr (2002) Global gene expression profiling of multiple myeloma,
monoclonal gammopathy of undetermined significance, and normal bone marrow plasma
cells. Blood 99:1745-1757
Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, Epstein J, Yaccoby S, Sawyer J,
Burington B, Anaissie E, Hollmig K, Pineda-Roman M, Tricot G, van Rhee F, Walker R,
Zangari M, Crowley J, Barlogie B, Shaughnessy JD Jr (2006) The molecular classification of
multiple myeloma. Blood 108:2020-2028
Zhao ZS, Lim JP, Ng YW, Lim L, Manser E (2005) The GIT-associated kinase PAK targets to
the centrosome and regulates Aurora-A. Mol Cell 20:237-249
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S (1998) Tumour
amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transfor-
mation. Nat Genet 20:189-193
Zojer N, Schuster-Kolbe J, Assmann I, Ackermann J, Strasser K, Hubl W, Drach J, Ludwig H
(2002) Chromosomal aberrations are shared by malignant plasma cells and a small fraction of
circulating
CD19 ? cells
in
patients
with
myeloma
and
monoclonal
gammopathy
of
undetermined significance. Br J Haematol 117:852-859
Zollinger A, Stuhmer T, Chatterjee M, Gattenlohner S, Haralambieva E, Muller-Hermelink HK,
Andrulis M, Greiner A, Wesemeier C, Rath JC, Einsele H, Bargou RC (2008) Combined
functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma
subgroups: Akt-dependent and Akt-independent multiple myeloma. Blood 112:3403-3411
